NEWS

A contract manufacturer serving medical device and pharmaceutical OEMs, Gerresheimer offers small series production capabilities at its Technical Competence Center in Peachtree City, GA. Small quantities of products can be manufactured under series conditions and in an ISO Class 8 cleanroom. Small series production is typically needed for clinical samples or stability batches during the…

Belgian biotech firm UCB SA said on Monday the U.S. Food and Drug Administration (FDA) approved its drug to treat seizures associated with Lennox-Gastaut Syndrome (LGS), a rare form of childhood epilepsy. The drug, branded as Fintepla, already has the U.S. approval to treat another form of childhood-onset epilepsy, Davet Syndrome (DS), in patients aged…

Researchers have identified antibodies that may be able to defend people against multiple species of the Ebola virus family. The antibodies were derived from two individuals who survived Ebola virus disease and were treated at Emory University Hospital in 2014. The findings were published in Cell, following a collaboration between the lab of Rafi Ahmed, PhD,…

Mercer University is one of three recipients of the worldwide Council on Undergraduate Research’s (CUR) Campus-Wide Award for Undergraduate Research Accomplishments (AURA). The annual award, which recognizes institutions with exemplary programs that provide high-quality research experiences for undergraduates, will be formally presented during a virtual ceremony on April 21 as part of national Undergraduate Research Week.…

Approval based on data where fenfluramine demonstrated efficacy in the most difficult to treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle tone, become limp, and fall to the ground with a high likelihood of injury3 LGS is a severe childhood-onset developmental and epileptic encephalopathy characterized by drug-resistant seizures with high…

IND-Enabling Studies Underway for MVA-VLP-MUC1 Vaccine Candidate GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that the U.S. Patent and Trademark Office has issued Patent No. 11278607 to GeoVax, pursuant to the Company’s patent application No. 16/068,527 entitled “Compositions and Methods for Generating an…